ADGM · Adagio Medical Holdings, Inc.

$0.41 -0.04 (-8.40%) At close · Jul 29

Market Cap

$9.11M

22.21M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Usen	CEO	$500,000	$330,000	—	$1,631,865	—	$38,608	$2,500,473
Deborah Kaster	CFO	$251,902	$101,097	—	$483,038	—	—	$836,037
Hakon Bergheim	COO	$53,937	—	—	—	—	$117,630	$171,567
John Dahldorf	CFO	$104,640	—	—	—	—	$49,037	$153,677

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Dahldorf	CFO	$425,000	$67,575	—	—	—	—	$492,575
Hakon Bergheim	COO	$323,621	$48,543	—	—	—	—	$372,164
Todd Usen	CEO	$22,917	—	—	—	—	—	$22,917
Deborah Kaster	CFO	—	—	—	—	—	—	—
Olav Bergheim	CEO	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Dahldorf	CFO	$283,333	$106,250	—	$309,700	—	—	$699,283
Hakon Bergheim	COO	$318,486	$69,347	—	—	—	—	$387,833
Olav Bergheim	CEO	—	$88,736	—	—	—	—	$88,736
Todd Usen	CEO	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Sean Salmon	Class II director	Appointed	2025-12-11	2025-12-11

Key facts CIK 2006986 CUSIP 00534B100 13F (30d) 2 filings 2 filers Visit website Investor relations